A recent study investigated the significance of quantifying amino acids in minute sweat volumes using high performance liquid chromatography (HPLC) with fluorescence (FL) detection, offering a non-invasive and efficient way to screen for diseases by detecting amino acids in sweat, even with minimal sweat volumes.
A joint study by the Graduate School of Pharmaceutical Sciences of the University of Tokyo (Japan) and Pico Device (Nagoya, Japan) investigated the significance of quantifying amino acids in minute sweat volumes using high performance liquid chromatography (HPLC) with fluorescence detection, offering a non-invasive and efficient way to screen for diseases by detecting amino acids in sweat, even with minimal sweat volumes. The approach, outlined in a recent article in the journal Heliyon (1), could also be used to analyze other biomolecules in sweat, expanding its potential applications.
The measurement of metabolites in biological samples other than blood has gained increasing significance due to the rising demand for non-invasive analytical methods, with sweat, saliva, and tears emerging as particularly relevant sources for such analyses (2), with sweat especially notable as a biofluid allowing for non-invasive, continuous, and real-time health monitoring (3–6). Primarily produced by specific bodily glands to regulate body temperature, hydrate the skin, and provide protection, sweat, while composed of about 99 % water, also contains essential ions like chloride, sodium, and potassium, along with smaller amounts of calcium, magnesium, lactate, and other minor electrolytes (7,8). Sweat also contains trace amounts of various substances which can offer valuable insights into the status of a person's health, thus making its analysis crucial in non-invasive health monitoring. Continuous monitoring of sweat metabolites can reveal real-time information on changes in the physiological and metabolic state of the body, making it a promising approach for personalized medicine and disease management(9,10).
Sweat samples of four healthy volunteers (male, 21–24 years old) from whom informed consent was obtained were collected in a temperature-controlled room set to 26 °C, although ambient humidity was not regulated. Sweat production was monitored at 1-min intervals for 5 min, and the average of these readings was used as the representative sweat volume. The use of this advanced perspiration meter ensures precise and accurate measurements for the analysis of bilateral palm perspiration. The HPLC system utilized was comprised of a PU-2080 pump, an AS-950 autosampler, an Inertsil ODS-4V column in a CO-965 column oven, and a FP-2020 fluorescence detector. Samples containing 0.01, 0.05, 1, 5, or 10 μM of each amino acid were injected into the HPLC system after derivatization. Calibration curves were generated by plotting the ratio of the peak area of each sample to that of the internal standard (ε-amino-n-caproic acid) against the concentration of these compounds (1).
The researchers were able to quantify the amino acid concentrations in human sweat samples, successfully identifying fourteen amino acids with robust validation data. The authors of the paper believe that their technique has the potential for non-invasive and straightforward disease screening, due to allowing for analysis without need for excessive sweat samples, such as an amount generated through exercise. Additionally, they imagine that the technique has potential applications in the detection of other biomolecules in sweat besides amino acids.
References
1. Tsunoda, M.;Tsuda, T. Quantification of Amino Acids in Small Volumes of Palm Sweat Samples. Heliyon 2024, 10 (17), e36286. DOI: 10.1016/j.heliyon.2024.e36286
2. Nair, R. R.; An, J. M.; Kim, J.; Kim, D. Recent Progress in Fluorescent Molecular Systems for the Detection of Disease-Related Biomarkers in Biofluids. Coord. Chem. Rev. 2023, 494, 215336. DOI: 10.1016/j.ccr.2023.215336
3. Davis, N.; Heikenfeld, J.; Milla, C.; Javey, A. The Challenges and Promise of Sweat Sensing. Nat. Biotech. 2024, 42, 860–871. DOI: 10.1038/s41587-023-02059-1
4. Sarwar, M.; Rodriguez, P.; Li, C. Z. Sweat-Based in vitro Diagnostics (IVD): From Sample Collection to Point-of-Care Testing (POCT). J. Anal. Test. 2019, 3, 80–88. DOI: 10.1007/s41664-019-00097-w
5. Yang, D. S.; Ghaffari, R.; Rogers, J. A. Sweat as a Diagnostic Biofluid. Science 2023, 379 (6634), 760–761. DOI: 10.1126/science.abq5916
6. Brasier, Noé et al.Next-Generation Digital Biomarkers: Continuous Molecular Health Monitoring Using Wearable Devices. Trends Biotechnol. 2024, 42 (3), 255–257. DOI: 10.1016/j.tibtech.2023.12.001
7. Hussain, J. N.; Mantri, N.; Cohen, M. M. Working up a Good Sweat–The Challenges of Standardising Sweat Collection for Metabolomics Analysis. Clin. Biochem. Rev. 2017, 38 (1), 13–34.
8. Baker, L. B.; Wolfe, A. S. Physiological Mechanisms Determining Eccrine Sweat Composition. Eur. J. Appl. Physiol. 2020, 120, 719–752. DOI: 10.1007/s00421-020-04323-7
9. Tsunoda, M.; Hirayama, M.; Tsuda, T.; Ohno, K. Noninvasive Monitoring of Plasma L-dopa Concentrations Using Sweat Samples in Parkinson's Disease. Clin. Chim. Acta 2015, 442, 52–55.DOI: 10.1016/j.cca.2014.12.032
10. Hirayama, M.; Tsunoda, M.; Yamamoto, M.; Tsuda, T.; Ohno, K. Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson’s Disease. J. Parkinson's Dis. 2016, 6 (2), 423–431. DOI: 10.3233/JPD-150736
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.